Clinical Trials
4 trialsNCT05741294 2025-02-20
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Almirall, S.A.
Phase 4 Completed
NCT05387525 2025-02-11
AKtive
Almirall, S.A.
Phase 4 Active not recruiting
NCT06026358 2024-05-30
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands
Medical University of Graz
Phase 4 Withdrawn
NCT05900258 2023-11-14
SunDamage
Medical University of Graz
Phase 4 Completed